RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · IEX Real-Time Price · USD
1.160
-0.040 (-3.33%)
At close: Jul 19, 2024, 4:00 PM
1.100
-0.060 (-5.17%)
Pre-market: Jul 22, 2024, 4:17 AM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $27.78 million as of July 22, 2024. Its market cap has increased by 34.87% in one year.
Market Cap
27.78M
Enterprise Value
23.40M
1-Year Change
34.87%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $27.78M, a decrease of -59.52%. That is a compound annual growth rate of -26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 27.80M | 13.47% |
| Dec 29, 2023 | 24.50M | 14.49% |
| Dec 30, 2022 | 21.40M | -50.35% |
| Dec 31, 2021 | 43.10M | -37.21% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 28.79M |
| bioAffinity Technologies | 28.56M |
| Enlivex Therapeutics | 28.28M |
| Palatin Technologies | 27.92M |
| Bolt Biotherapeutics | 27.87M |
| Brainstorm Cell Therapeutics | 27.56M |
| Acasti Pharma | 26.69M |
| Renalytix | 26.57M |